All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @stackedpeptides on TikTok · 78s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @stackedpeptides's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Hi, I'm Dr. Sarah Watley, medical director for stacked peptides. Today I'm going to show you
  2. 0:05a subcutaneous injection with a peptide. Right now I'm on a protocol using the Wolverine stack,
  3. 0:10which is TB-500 and BPC-157. I showed in another video doing an injection near my knee, which is
  4. 0:17my area of injury. You can use this peptide as a subcutaneous under the skin injection
  5. 0:22anywhere for full body benefits. Today I'm going to show you an injection in my abdomen. You can
  6. 0:28inject this in the back of the arm or also on your thigh. I already have my peptides all drawn up.
  7. 0:36I'm going to get my alcohol pad. Today we're going to do in the abdomen. You can kind of go
  8. 0:42above or below the belly button. You just want to be able to pinch an inch. We're going to clean
  9. 0:48the area. I'm going to take my peptides. You want to be able to pinch an inch. That way you
  10. 0:54have stability when you're doing your injection. You're going to inject where you cleaned, then
  11. 1:01you're going to deploy the peptide. And then boom, that's it. Recap your needle and don't
  12. 1:08forget to put it in your biohazard waste or back into your peptide box. If we've provided
  13. 1:13your peptides, you can turn those back into us so that we can dispose of those properly.

@stackedpeptides's peptide therapy claims, fact-checked

Stacked Peptides

TikTok creator

66.4K viewsWatch on TikTok

Quick answer

The video demonstrates subcutaneous injection of TB-500 and BPC-157, two research peptides with animal-based evidence for tissue repair but no FDA-approved indication in humans. The presenter is a physician performing a patient-facing instructional demonstration, which raises informed consent and regulatory questions about how these compounds are being dispensed. Neither peptide has completed Phase III human trials, and both are prohibited in competitive sports under WADA regulations.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @stackedpeptides's peptide therapy claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@stackedpeptides's peptide therapy claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@stackedpeptides's peptide therapy claims, fact-checked" from Stacked Peptides. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video demonstrates subcutaneous injection of TB-500 and BPC-157, two research peptides with animal-based evidence for tissue repair but no FDA-approved indication in humans.

The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7577987377021357343." In this clip, the useful excerpt is: "Hi, I'm Dr." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Animal studies show tissue repair signals, but the leap from rodent data to human therapeutic use is not supported by current evidence.
People who land here are usually trying to understand whether the Peptide social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video demonstrates subcutaneous injection of TB-500 and BPC-157, two research peptides with animal-based evidence for tissue repair but no FDA-approved indication in humans.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video demonstrates subcutaneous injection of TB-500 and BPC-157, two research peptides with animal-based evidence for tissue repair but no FDA-approved indication in humans. The presenter is a physician performing a patient-facing instructional demonstration, which raises informed consent and regulatory questions about how these compounds are being dispensed. Neither peptide has completed Phase III human trials, and both are prohibited in competitive sports under WADA regulations.
  • Neither BPC-157 nor TB-500 is FDA-approved for any human indication. Both are classified as research chemicals and lack completed Phase III human clinical trial data.
  • Animal studies show tissue repair signals, but the leap from rodent data to human therapeutic use is not supported by current evidence. Seiwerth et al. (2018, Current Pharmaceutical Design) reviewed BPC-157 animal data but noted the absence of human trials.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Neither BPC-157 nor TB-500 is FDA-approved for any human indication. Both are classified as research chemicals and lack completed Phase III human clinical trial data.
  • Animal studies show tissue repair signals, but the leap from rodent data to human therapeutic use is not supported by current evidence. Seiwerth et al. (2018, Current Pharmaceutical Design) reviewed BPC-157 animal data but noted the absence of human trials.
  • Both compounds are on WADA's 2024 Prohibited List under Section S2 (Peptide Hormones and Growth Factors). Competitive athletes face sanction risk regardless of how they obtained them.
  • The 'inject anywhere for full body benefits' claim is not established in human pharmacokinetic data. Localized injection near an injury site may behave differently than distal subcutaneous injection.
  • The CDC recommends a one-handed scoop technique for needle recapping, not two-handed recapping, to reduce needlestick injury risk.
  • Compounded peptides dispensed through telehealth platforms are not subject to the same FDA quality controls as approved drugs. Purity, sterility, and accurate dosing cannot be assumed without third-party certificate of analysis documentation.
  • The 'Wolverine stack' is a marketing term with no clinical definition. No peer-reviewed literature uses this terminology or has studied this specific combination protocol in humans.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @stackedpeptides actually say?

Dr. Sarah Watley, who identifies herself as medical director for Stacked Peptides, demonstrates a subcutaneous injection of what she calls the "Wolverine stack" — a combination of TB-500 and BPC-157. She says you can inject these peptides "anywhere for full body benefits" and walks through abdomen injection technique, including pinching skin, cleaning the site, and proper sharps disposal.

The video is straightforwardly instructional. She is not selling a miracle cure here — she is showing injection technique to what appears to be an existing patient or customer base. That framing matters. But several background claims embedded in this demonstration deserve a harder look.

Does the science back this up?

On TB-500 and BPC-157 specifically, the honest answer is: the animal data is interesting, the human data is thin. Neither peptide has completed Phase III clinical trials in humans. The "full body benefits" claim from systemic subcutaneous injection is plausible mechanistically but not established in human evidence.

TB-500 is a synthetic fragment of Thymosin Beta-4, a protein involved in actin regulation and tissue repair. Rodent studies have shown accelerated wound healing and cardiac repair (Goldstein et al., 2012, Annals of the New York Academy of Sciences). BPC-157 is a pentadecapeptide derived from a gastric protein. Animal research suggests it may support tendon-to-bone healing and reduce inflammation (Seiwerth et al., 2018, Current Pharmaceutical Design). Neither compound has been approved by the FDA for any indication. Calling this protocol "the Wolverine stack" is marketing language, not clinical terminology. That framing obscures the experimental nature of what is being injected.

What did they get wrong (or right)?

The injection technique itself is largely correct. Pinching an inch of subcutaneous tissue, cleaning with alcohol, and using proper sharps disposal are standard subcutaneous injection practices consistent with nursing and pharmacy guidelines. Credit where it is due: she reinforces sharps disposal and even offers to take used equipment back for proper disposal. That is responsible harm reduction.

Where the video falls short is the phrase "full body benefits" from any injection site. This implies systemic bioavailability and therapeutic equivalence regardless of injection location. That is not well-established for either compound. Some researchers hypothesize local injection near an injury site may be more effective for tissue-level effects (Chang et al., 2011, Journal of Applied Physiology), but this remains debated. She actually contradicts herself slightly here — she mentioned in a previous video injecting near her knee for her injury, which implies local targeting matters. You cannot have it both ways.

There is also no discussion of sourcing, purity, or the regulatory status of these compounds. Compounded peptides sold outside of FDA-approved drug pathways vary significantly in quality and sterility. That omission is meaningful in a video that is functionally instructional.

What should you actually know?

Both TB-500 and BPC-157 are on WADA's prohibited list, meaning any athlete subject to anti-doping testing could face consequences for use. Neither is FDA-approved, and both are classified as research chemicals in most regulatory frameworks. That does not make them automatically dangerous, but it does mean there is no standardized dosing, no established safety profile from large human trials, and no regulatory oversight of quality.

Subcutaneous injection itself carries real risks: infection, lipodystrophy from repeated injections in the same site, and incorrect technique leading to intramuscular injection when subcutaneous was intended. The video addresses some of this but not all. Anyone considering peptide therapy through a telehealth platform should ask specific questions about sourcing, third-party testing, and what informed consent looks like in writing.

The "Wolverine stack" name is a marketing construct. Wolverine heals fictionally. These compounds show promise in animals. That gap matters.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Stacked Peptides · TikTok creator

66.4K views on this video

@stackedpeptides's peptide therapy claims, fact-checked

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about neither bpc-157 nor tb-500?

Neither BPC-157 nor TB-500 is FDA-approved for any human indication. Both are classified as research chemicals and lack completed Phase III human clinical trial data.

What does the video say about animal studies show tissue repair signals,?

Animal studies show tissue repair signals, but the leap from rodent data to human therapeutic use is not supported by current evidence. Seiwerth et al. (2018, Current Pharmaceutical Design) reviewed BPC-157 animal data but noted the absence of human trials.

What does the video say about both compounds?

Both compounds are on WADA's 2024 Prohibited List under Section S2 (Peptide Hormones and Growth Factors). Competitive athletes face sanction risk regardless of how they obtained them.

What does the video say about the 'inject anywhere for full body benefits' claim?

The 'inject anywhere for full body benefits' claim is not established in human pharmacokinetic data. Localized injection near an injury site may behave differently than distal subcutaneous injection.

What does the video say about the cdc recommends a one-handed scoop technique for needle recapping,?

The CDC recommends a one-handed scoop technique for needle recapping, not two-handed recapping, to reduce needlestick injury risk.

What does the video say about compounded peptides dispensed through telehealth platforms?

Compounded peptides dispensed through telehealth platforms are not subject to the same FDA quality controls as approved drugs. Purity, sterility, and accurate dosing cannot be assumed without third-party certificate of analysis documentation.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Stacked Peptides, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.